“Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study”, Bangladesh J Pharmacol, vol. 11, no. 3, pp. 564–569, Jun. 2016, doi: 10.3329/bjp.v11i3.23953.